Cargando…

The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial

Probiotics plus dietary fiber has demonstrated efficacy in improving metabolic abnormalities. However, the efficacy of probiotics and dietary fiber as well as their association with microbiota in attenuating antipsychotic-induced weight gain and metabolic disturbance remains poorly understood. Here...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jing, Liu, Chenchen, Yang, Ye, Kang, Dongyu, Xiao, Jingmei, Long, Yujun, Lang, Bing, Peng, Xingjie, Wang, Weiyan, Wang, Xiaoyi, Liu, Fangkun, Zhao, Jingping, Shi, Zhe, Yuan, Ti-Fei, Wu, Renrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068806/ https://www.ncbi.nlm.nih.gov/pubmed/35508529 http://dx.doi.org/10.1038/s41398-022-01958-2

Ejemplares similares

Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials
por: Huang, Jing, et al.
Publicado: (2022)

Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial
por: Liu, Chenchen, et al.
Publicado: (2021)

Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
por: Kang, Dongyu, et al.
Publicado: (2018)

Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
por: Yang, Ye, et al.
Publicado: (2022)

Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial
por: Xiao, Jingmei, et al.
Publicado: (2021)

Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex
por: Shao, Tiannan, et al.
Publicado: (2023)

Minocycline and antipsychotics inhibit inflammatory responses in BV-2 microglia activated by LPS via regulating the MAPKs/ JAK-STAT signaling pathway
por: Long, Yujun, et al.
Publicado: (2023)

Public Behavior Change, Perceptions, Depression, and Anxiety in Relation to the COVID-19 Outbreak
por: Huang, Jing, et al.
Publicado: (2020)

Identifying and revealing different brain neural activities of cognitive subtypes in early course schizophrenia
por: Shao, Tiannan, et al.
Publicado: (2022)

Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients
por: Wang, Juan, et al.
Publicado: (2013)

Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial
por: Long, Yujun, et al.
Publicado: (2023)

Effects of Clozapine and other Atypical Antipsychotics on Infants Development Who Were Exposed to as Fetus: A Post-Hoc Analysis
por: Shao, Ping, et al.
Publicado: (2015)

S2. ANTIPSYCHOTICS RESULT IN WEIGHT GAIN BUT THE SEVERITY OF WEIGHT GAIN DIFFERS BETWEEN ANTIPSYCHOTICS
por: Bak, Maarten, et al.
Publicado: (2020)

The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
por: Li, Ranran, et al.
Publicado: (2018)

Efficacy of probiotics and fibers on metabolic disturbances associated with antipsychotics: A systematic review and network meta-analysis
por: Soliman, Y., et al.
Publicado: (2023)

Tranylcypromine Causes Neurotoxicity and Represses BHC110/LSD1 in Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids Model
por: Huang, Jing, et al.
Publicado: (2017)

Effects of sulforaphane on cognitive function in patients with frontal brain damage: study protocol for a randomised controlled trial
por: Liu, Fangkun, et al.
Publicado: (2020)

Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia
por: Kakunje, Anil, et al.
Publicado: (2018)

Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis
por: Bak, Maarten, et al.
Publicado: (2021)

Altered gene expression in antipsychotic-induced weight gain
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2019)

Combination approaches to reduce weight-gain induced by antipsychotics
por: Hofer, A.
Publicado: (2021)

Biological Mechanism(s) Underpinning the Association between Antipsychotic Drugs and Weight Gain
por: Panizzutti, Bruna, et al.
Publicado: (2021)

Successful Use of Add - On Topiramate for Antipsychotic - Induced Weight Gain
por: Shivakumar, Venkataram, et al.
Publicado: (2012)

Youth, Caregiver, and Prescriber Experiences of Antipsychotic-Related Weight Gain
por: Murphy, Andrea Lynn, et al.
Publicado: (2013)

The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
por: Bretler, Tali, et al.
Publicado: (2019)

The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
por: Libowitz, Mark R., et al.
Publicado: (2021)

Association between olanzapine concentration and metabolic dysfunction in drug-naive and chronic patients: similarities and differences
por: Kang, Dongyu, et al.
Publicado: (2022)

Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
por: Bak, Maarten, et al.
Publicado: (2014)

The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
por: Morgan, Andrew P., et al.
Publicado: (2014)

Risk of weight gain for specific antipsychotic drugs: a meta-analysis
por: Spertus, Jacob, et al.
Publicado: (2018)

Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
por: Dayabandara, Madhubhashinee, et al.
Publicado: (2017)

Sex differences in gene expression related to antipsychotic induced weight gain
por: Sainz, Jesus, et al.
Publicado: (2019)

Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
por: Grajales, Diana, et al.
Publicado: (2019)

Antipsychotic-Induced Weight Gain and Clinical Improvement: A Psychiatric Paradox
por: Garcia-Rizo, Clemente
Publicado: (2020)

Conserved immunomodulatory transcriptional networks underlie antipsychotic-induced weight gain
por: Zapata, Rizaldy C., et al.
Publicado: (2021)

Risk factors and pattern of weight gain in youths using antipsychotic drugs
por: van der Esch, Casper C. L., et al.
Publicado: (2020)

Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain
por: Schreyer, Korbinian Felix, et al.
Publicado: (2023)

TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese
por: Li, Shen, et al.
Publicado: (2017)

Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
por: Wu, Haishan, et al.
Publicado: (2013)

The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain
por: Li, Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h73v3nde143df9h40lunbn7pa8